Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.
about
Endoglin in liver fibrogenesis: Bridging basic science and clinical practiceDevelopment and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular CarcinomaMechanism of endothelial progenitor cell recruitment into neo-vessels in adjacent non-tumor tissues in hepatocellular carcinoma.Peritumoral Neuropilin-1 and VEGF receptor-2 expression increases time to recurrence in hepatocellular carcinoma patients undergoing curative hepatectomyMicrovascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpressionKidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinomaHigher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.Co-evolution of tumor-associated macrophages and tumor neo-vessels during cervical cancer invasionMacrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma.Collagen as a double-edged sword in tumor progression.Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells.Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis.Thyroid hormone suppresses cell proliferation through endoglin-mediated promotion of p21 stability.Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera.Inhibition of poly adenosine diphosphate-ribose polymerase decreases hepatocellular carcinoma growth by modulation of tumor-related gene expression.Close association of metastasis-associated protein 1 overexpression with increased angiogenesis and poor survival in patients with histologically node-negative gastric cancer.
P2860
Q33728841-A3ADD99F-FA37-419F-8FB6-4FD5D85D0C5FQ33911829-BFEC3E56-F8AA-4E6A-92DD-B16187B663FDQ34114213-83B517C9-3CEF-4C17-B849-1D4EA31BC23EQ34956865-F690DBE9-D915-430C-B97B-4D78D6EF890BQ35089199-C70C795A-69CA-49B0-BD1F-4DF322011C6BQ35781367-3D0F7FED-C3C7-406E-9963-73A773E247B4Q35829509-CB9CCC7A-535A-4590-BDF0-AFFF423B4489Q37288659-DE394C29-81E0-4266-B460-D60CFBED8090Q37359619-BE32CC98-E17C-44FE-8B81-BCC2871CDE19Q37692855-CDFF29AA-D7D6-403A-BAFE-F6DAE7CD951AQ37820212-1642BCBE-456B-4D4C-BEB1-8E926072529DQ38631740-A3C85364-BA28-4F53-A907-F5CF8FD671C4Q39200344-199482BC-9155-41B4-BF44-9DBAEBB25354Q39450324-45283D2D-7ABA-4206-AFC7-B227DA9B4581Q42831020-E729DDDF-545B-41E8-A580-CE5E7438E927Q45135596-30F87D11-E8B2-493C-8387-55943C7681A3
P2860
Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Particular distribution and ex ...... with hepatocellular carcinoma.
@ast
Particular distribution and ex ...... with hepatocellular carcinoma.
@en
Particular distribution and expression pattern of endoglin
@nl
type
label
Particular distribution and ex ...... with hepatocellular carcinoma.
@ast
Particular distribution and ex ...... with hepatocellular carcinoma.
@en
Particular distribution and expression pattern of endoglin
@nl
prefLabel
Particular distribution and ex ...... with hepatocellular carcinoma.
@ast
Particular distribution and ex ...... with hepatocellular carcinoma.
@en
Particular distribution and expression pattern of endoglin
@nl
P2093
P2860
P356
P1433
P1476
Particular distribution and ex ...... with hepatocellular carcinoma.
@en
P2093
Linyuan Zhuang
Yitao Ding
Yongzhong Yao
P2860
P2888
P356
10.1186/1471-2407-7-122
P407
P577
2007-07-04T00:00:00Z
P5875
P6179
1021734932